Acute Promyelocytic Leukemia (APL): Clinical Overview, Risk Stratification, Diagnosis, and Modern Management

I. Introduction & Pathobiology Acute promyelocytic leukemia (APL; AML-M3, FAB classification) is a distinct, life-threatening subtype of acute myeloid leukemia (AML) accounting for 10–15% of AML cases in adults and…

Continue ReadingAcute Promyelocytic Leukemia (APL): Clinical Overview, Risk Stratification, Diagnosis, and Modern Management

Acute Lymphoblastic Leukemia (ALL): Comprehensive Clinical Review for Practicing Oncologists and Hematologists

Epidemiology and Pathobiology: Clinical Relevance Acute lymphoblastic leukemia (ALL) accounts for ~75% of acute leukemias in children but only ~20% in adults, with a median age at diagnosis of ~65…

Continue ReadingAcute Lymphoblastic Leukemia (ALL): Comprehensive Clinical Review for Practicing Oncologists and Hematologists

Chronic Myelomonocytic Leukemia (CMML): A Clinically Focused Update for Hematologists and Oncologists

Epidemiology & Pathogenesis CMML is a clonal hematopoietic stem cell disorder classified under the myelodysplastic/myeloproliferative neoplasm (MDS/MPN) overlap syndromes. It exhibits features of both dysplasia and proliferation, with characteristic persistent…

Continue ReadingChronic Myelomonocytic Leukemia (CMML): A Clinically Focused Update for Hematologists and Oncologists